Psoriasis Diet Diary Week Twenty Three
Another great week. Skin is improving rapidly on my arms and legs, and continues to disappear from my torso and back. The last two weeks has not included potatoes and grains, which I will carry...
By: Jon Maddison
Read the original:
DARK CIRCLES, DISCOLORATION, PSORIASIS
Question: Hey Rita, I am still waiting on your response. I hope you haven #39;t forgotten. I will list the questions here again. I understand If you don #39;t know the answer to my problem. I will...
By: RitaSpeaks
The rest is here:
Blender Game Engine: Bald head, Psoriasis and Lice
Small game, currently unfinished. The War on an head coming soon :D.
By: Raketenbaum
Read more from the original source:
Heal psoriasis quickly
I grew up living with psoriasis, and now as an adult I live totally SYMPTOM FREE! This video is kind of long, but theres a lot to discuss when it comes to psoriasis. My heart aches for those...
By: Holistic Chick
Read the original post:
Tampa dermatologist Dr. Seth Forman, one of a selected few physicians to offer innovative treatments, is relieving even the most severe conditions of eczema and psoriasis
To help alleviate these harsh diseases, Dr. Forman offers the most advanced treatments and conducts ongoing clinical trials to help find the most effective remedies.
While many will just chalk it as a simple skin disease, I take eczema and psoriasis very seriously, says the Tampa dermatologist. These conditions can be debilitating for those suffering from them, not just cosmetically, but physically.
Also called atopic dermatitis, eczema is an itchy red rash that can appear all over the body according to the National Eczema Association. Approximately 30 million people, mostly children, in the United States suffer from the condition.
Psoriasis is an autoimmune disease that causes raised, red, scaly patches to appear on the skin, per the National Psoriasis Foundation. The disease often develops between the ages of 15 and 35.
Eczema and psoriasis can be unbearable for people affected with the condition, but my office has been dedicated to easing the pain, physically and emotionally for our patients, continued Dr. Forman.
With access to the newest and most effective treatments, weve been able to help the most extreme cases reduce, or show absolutely no signs of, these unsightly ailments.
The Tampa dermatologist is currently enrolling patients in clinical trials for both skin diseases. For more on Dr. Seth Forman, Tampa dermatology or Forman Dermatology and Skin Cancer Institute, please visit http://www.FormanDerm.com.
About Dr. Seth Forman:Dr. Forman is a board-certified dermatologist practicing in Tampa, Florida. He was voted the Best Dermatologist in Carrollwood in 2011 and 2012 by the Carrollwood News and Tribune. In December 2011, he opened his new Tampa dermatologyoffice, Forman Dermatology and Skin Cancer Institute, where he gives psoriasis sufferers access to the latest treatment options, including topical and oral medications, as well as biological and phototherapy. Dr. Forman is one of the few Tampa dermatologists to offer narrowband light therapy, which uses pharmaceutical grade light to suppress psoriasis. Hes also one of the few board-certified dermatologists in the U.S. to use the SRT-100 radiotherapy to treat basal cell carcinoma, the most common form of skin cancer.
MEDIA CONTACT Nathan Legg PR Firm: The Publicity Agency Email:Nathan@SeligMultimedia.com Phone: (813) 708-1220 x 7781 Website:www.thepublicityagency.com
View original post here:
Tampa dermatologist easing severe eczema and psoriasis cases with cutting edge treatment
PORTLAND, Ore., March 26, 2015 /PRNewswire-USNewswire/ -- Americans with chronic diseases like psoriasis and psoriatic arthritis may be better able to afford vital medication to effectively manage their conditions, thanks to bipartisan legislationthe Patients' Access to Treatments Act (PATA)introduced in Congress yesterday.
The legislation, introduced in the U.S. House of Representatives by Reps. David McKinley (R-WV) and Lois Capps (D-CA), aims to lower out-of-pocket costs for systemic and biologic drugs, which are used to treat chronic and disabling diseases like psoriatic disease, rheumatoid arthritis and lupus, and cancers like leukemia and lymphoma. These drugs are often placed on "specialty tiers," where a portion of the total cost of the drug is passed on to patients, called a coinsurance.
Learn more about PATA and its impact on people with psoriatic disease: http://www.psoriasis.org/pata-info.
Specialty drugs for psoriasis and psoriatic arthritis cost millions of Americans upwards of $1,500 to $5,000 per month in out-of-pocket costs. According to a 2015 study examining the economic burden of psoriasis, total direct costs of the diseasesuch as medical expenses from doctor's appointments and treatments--can cost upwards of $8,000 per person annually.
PATA will improve treatment adherence and health outcomes for chronic diseases by making medically necessary medication more accessible. In a recent National Psoriasis Foundation survey, more than 22 percent of respondents said cost was a barrier to accessing the treatments they need to manage their disease and avoid health complications.
"Psoriasis is a painful, chronic, noncontagious autoimmune disease without a cure, costing our society up to $135 billion annually. Up to 30 percent of people with psoriasis develop psoriatic arthritis," said Randy Beranek, National Psoriasis Foundation president and CEO. "Access to safe and effective treatments is the number one challenge for our community. PATA will lower out-of-pocket costs on needed medications so millions with psoriatic disease can better manage their condition."
As part of the Coalition for Accessible Treatments a partnership of 32 patient and provider organizations that created the PATA legislation the National Psoriasis Foundation fights for fair and affordable access to treatments for millions of Americans with psoriasis and psoriatic arthritis. These are serious, systemic autoimmune diseases with a profound physical, social, psychological and financial burden.
Psoriasis, the most common autoimmune disease in the country, increases people's risk for heart disease, heart attack, stroke and early death. Treatment with systemic and biologic drugs can reduce a person's risk for these comorbidities. Additionally, treating psoriatic arthritis early and effectively can prevent irreversible joint damage.
To learn more about the Patient's Access to Treatments Act and urge your member of Congress to support this legislation, visit http://www.psoriasis.org/pata-info.
About the National Psoriasis FoundationNational Psoriasis Foundation (NPF) is the world's largest nonprofit serving those with psoriasis and psoriatic arthritis. Our priority is to provide the services people need to take control of their condition, while increasing research to find a cure. In addition to serving more than 2.1 million people annually through our education and advocacy initiatives, NPF has funded more than $11 million in psoriatic disease research grants and fellowships. Learn more at http://www.psoriasis.org or call 800.723.9166. Follow us on Facebook and Twitter.
Read more from the original source:
National Psoriasis Foundation backs bill to lower treatment cost
Minimalist Packing For World Travel
A bunch of people have asked me to share my travel gear and after much research and actual trip experience, this is the most up to date list of my gear for traveling the world! When I made...
By: ddferrer
Continue reading here:
FSX VATSIM HELI Helicopter World Travel Flight 81 KMIA
FSX VATSIM HELI Helicopter World Travel Flight 81 KMIA -- Watch live at http://www.twitch.tv/jacktung077.
By: Jack Tung
More here:
FSX VATSIM HELI Helicopter World Travel Flight 81 KMIA - Video
ATDD in the World Travel Market (WTM-London) 2014
leading the Ajman delegation to the exhibition expected to gather the most influential figures in the travel industry from around the world. The event is considered a good opportunity to review...
By: Ajman Tourism Development Department
Original post:
Cube World - 110 - Caving and Castle Smashing - RPG Alpha Gameplay LP (Warrior)
In this episode, Orco is back and rolling in the lands of Cube and delving into some dark caves in search of loots! Then it #39;s off to find the next ruler to REK! Check out Rivet #39;s adventures...
By: Armourtime
See the original post here:
Cube World - 110 - Caving and Castle Smashing - RPG Alpha Gameplay LP (Warrior) - Video
Drake Bay Wilderness Resort, Costa Rica
Drake Bay Wilderness Resort in Drake Bay, Osa Peninsula, Costa Rica Travel Videos HD, World Travel Guide http://www.youtube.com/subscription_center?add_user=World1Tube We are a beach ...
By: World Travel Guides
Read the original here:
Conference Features Successful Roll out of Advanced Principles of Business Travel Management Pilot Session
The Global Business Travel Association (GBTA) Mexico hosted its 9th annual GBTA Mexico Conference 2015 from March 18 - 20 at the World Trade Center in Mexico City. A record number of more than 390 business travel professionals attended the event from Mexico, the United States and Latin America.
Attendees were given the opportunity to participate in educational sessions and an expanded trade show floor to grow their industry knowledge and contacts, and to spark innovative ideas about corporate travel management in the face of global economic crises.
"During the last few years, business travel in our country has shown considerable growth; no doubt this has been a great benefit for all those individuals and companies that comprise our industry," said Isabel Gomez, president of GBTA Mexico. "This conference is very special for us; it is a milestone in the consolidation of the Global Business Travel Association and its leadership in Latin America. The measure in which we grow professionally will help us to meet the challenges on the horizon in our expanding economy."
This year's Conference featured a presentation from GBTA Past President and Chairman Kevin Maguire, who emphasized the importance of Latin America for GBTA and its continued growth as a major region for continuing business travel education. Education was highlighted as 180 attendees took part in the successful roll out of the pilot program for The Principles of Business Travel Management course. The two-day workshop led by subject-matter experts featuring high-level discussion on a wide-range of industry best practices will debut at GBTA's 2015 convention in Orlando, Florida, July 25 - 29.
Conference attendees also had the opportunity to hear from leading industry speakers including:
For more information, visit http://www.gbta.org/mexico.
About GBTA Mexico Founded in 2007, GBTA Mexico is the only Mexican corporate travel organization. GBTA Mexico is an important part of America Latina of the Global Business Travel Association (GBTA), the world's premier business travel and meetings organization. Collectively, GBTA's 7,000-plus members manage over $345 billion of global business travel and meetings expenditures annually. GBTA and the GBTA Foundation deliver world-class education, events, research, advocacy and media to a growing global network of more than 28,000 travel professionals and 125,000 active contacts. To learn how business travel drives business growth, visit gbta.org.
Read the original:
CAPE TOWN, South Africa, March 27, 2015 /PRNewswire/ --
WAYN.com (Where Are You Now), the world's largest travel and lifestyle community with 23 million travellers revealed today the extent of its partnership with South Africa Tourism. Over the last 6 years, and further various digital marketing initiatives on the WAYN platform, over 280,000 users added a trip to South Africa. Further research and user profile data confirmed circa $600 on tourism activities per traveller over a 6 days average stay, excluding air travel (source: WAYN Insights). This represents circa $168,000,000 of tourism spend in the country or circa R2bn, since 2009.
(Logo: http://photos.prnewswire.com/prnh/20150327/736452 )
The top countries of origin included France, India, Mauritius, the UK, US, Germany and the UAE which represent nearly 50% of all arrivals.
In addition to the spend generated in the country, South Africa Tourism benefits from an active audience of 712,000 fans globally and this has been growing at a rate of 410 fans daily. South Africa Tourism also confirmed that over 840,000 WAYN users have expressed strong intentions to visit the country.
Jerome Touze, co-founder of WAYN.com said: ''having relocated myself to South Africa, I am very pleased to see how attractive this destination is getting each year. The French, American and Indian markets are ones to watch out for with strong interests originating from thosedestinations.
He added: "I am a big fan of South Africa. The sheer beauty of this country and the diversity of the landscapes as well as the warmth of its people must be experienced at least once in your lifetime"
William Price, Global Manager of Digital at South Africa Tourism said: "Our partnership with WAYN.com continues to deliver massive value for us as a destination, which also demonstrates our willingness to build equity into Social Networks where travelers are sharing inspiration and information to travel more. This is where we believe there are massive opportunities to grow our awareness, arrivals and positivity"
WAYN.com allows users from all over the world to discover new destinations to travel to and seek to inspire other users via the experiences and contributions from other travellers and locals. The site recently launched a Social Opinion engine, which is now generating over 50,000 opinions daily. WAYN.com attracts over 120,000,000 visitors annually.
Follow this link:
WAYN.com Generates $168,000,000 of Tourism Spend in South Africa
Maria Konovalenko Mikhail Batin at Transhuman Strategies conference (2015.03.21)
Russian immortality activists Maria Konovalenko and Mikhail Batin give an inspirational speech at the Transhuman Strategies conference on March 21, 2015 organized by Hank Pellissier #39;s Brighter...
By: Anatoly Karlin
See the original post:
Maria Konovalenko & Mikhail Batin at Transhuman Strategies conference (2015.03.21) - Video
A new video has appeared for Operation Abyss: New Tokyo Legacy, giving a quick initiation for new recruits to the game's Xth Squad. Full name the Xion Transhuman Squad, the Xth's job is to counter the threat of Variants, genetically-engineered monsters that appear through mysterious portals connected to a dimension known as the Abyss. The Xth is under the command of the Code Physics Agency, which works under the guise of a private school named Hinowa Academy and provides the squad with special weapons to use against the Variants.
Operation Abyss: New Tokyo Legacy is a spiritual successor to Demon Gaze, with players controlling a party of up to six through first-person dungeons. The game is set to be released by NIS America for PlayStation Vita on June 9, 2015 in North America and June 5, 2015 in Europe.
See the article here:
Developing stem cell therapy as an alternative to corneal transplants.
Professor Julie Daniels talks about her tissue engineering research.
By: Fight for Sight
Read the original post:
Developing stem cell therapy as an alternative to corneal transplants. - Video
Chia medical tourism--stroke--stem cell therapy 3.flv
Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, t...
Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, t...
Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, t...
Millions of stem cells derived from the bone marrow of healthy adult donors have been implanted in the brains of two stroke survivors at UPMC, as part of a t...
Visit our website "http://www.rejuvenare.com/ or contact us directly at (407) 255-2348 or email "info@rejuvenare.com". Stem cell therapy for stroke. Learn mo...
Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, t...
Brando, a 9 year-old German Shepard received combination stem cell therapy today at Paradise Animal Clinic by Dr. Jose Gorostiza (surgeon) and Dr. Jaime Paus...
http://www.chineitsang.co/chi-nei-tsang-1-massage-course-with-sarina-stone/112/
http://www.euromedic4arab.com/ cancer treatment in germany breast cancer treatment in germany prostate cancer treatment in germany cancer treatment in german...
See the original post:
A federal public servant has lost a legal bid to have taxpayers pay for experimental stem cell treatment on his dodgy knees.
The Administrative Appeals Tribunal has knocked back an appeal by Customs officer Vic Kaplicas to force insurer Comcare to pay $13,400 for the new treatment, instead saying he could have a tried-and-tested double knee replacement.
But the 49-year-old border official says he worries he cannot pass his department's fitness tests if he undergoes the knee replacements, which will leave him unable to run.
Advertisement
The former triathlete, who had to give up his sport because of his bad knees, said he was keen to avoid the "radical but effective" replacements for as long as possible.
Mr Kaplicas hurt his left knee working at Sydney's Mascot Airport in 2000, then injured his right knee 10 years later at Kingsford-Smith.
He managed the pain in his knees, which have since developed osteoarthritis, for years using over-the-counter painkillers, physio, exercises and injections but Mr Kaplicas' doctors say a more permanent solution is now needed.
In June 2012, Sydney knee specialist Sam Sorrenti asked Comcare to pay for bilateral knee stem cell assisted arthroscopic surgery for Mr Kaplicas.
The cost of the procedure was estimated at $13,464.00 for arthroscopy, stem cell harvesting and injection, and a "HiQCell procedure".
Dr Sorrenti said the knee replacements were not a good idea for a man of Mr Kaplicas' age, arguing the new knees would last 15 years at best, were intended for older people who are less concerned with physical activity, and left no further options.
See the rest here:
Irvine, Calif., March 26, 2015 -- Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center at UC Irvine has been awarded $5 million by the California Institute for Regenerative Medicine to continue her CIRM-funded effort to develop stem cell treatments for Huntington's disease.
The grant supports her next step: identifying and testing stem cell-based treatments for HD, an inherited, incurable and fatal neurodegenerative disorder. In this project, Thompson and her colleagues will establish an HD therapy employing human embryonic stem cells that can be evaluated in clinical trials.
Over the past seven years, Thompson, a UCI professor of psychiatry & human behavior and neurobiology & behavior, and her team have used CIRM funding to produce stem cell lines "reprogrammed" from the skin cells of individuals carrying the Huntington's genetic mutation in order to study the disease. In addition, they conducted basic and early-stage transitional studies to develop a stem cell-based technique to treat areas of the brain susceptible to HD.
"These stem cells offer a possible long-term treatment approach that could relieve the tremendous suffering experienced by HD patients and their families," said Thompson, who's also affiliated with UCI's Institute for Memory Impairments and Neurological Disorders (UCI MIND). "We appreciate CIRM and the millions of people in the state of California for generously supporting breakthrough stem cell research."
With this award, CIRM has granted Thompson $10.3 million for her HD work. Overall, UCI has received $105 million from the state-funded agency.
Thompson said that her group has identified a highly promising neural stem cell line that shows disease-modifying activity in HD mice. These neural stem cells were grown from human embryonic stem cells at UC Davis. The researchers also will conduct essential preclinical efficacy and safety studies in HD mice with these cells.
Over the span of the 2-year grant, Thompson said, the goal is to finalize work that will lead to a pre-investigational-new-drug meeting with the Food & Drug Administration and a path forward for clinical trials with the neural stem cells.
"This investment will let us further test the early promise shown by these projects," said Jonathan Thomas, chair of the CIRM governing board. "Preclinical work is vital in examining the feasibility, potential effectiveness and safety of a therapy before we try it on people. These projects all showed compelling evidence that they could be tremendously beneficial to patients. We want to help them build on that earlier research and move the projects to the next level."
HD is a devastating degenerative brain disorder with no disease-modifying treatment or cure. Current approaches only address certain symptoms of HD and do not change its course.
###
Read more:
UCI team gets $5 million to create stem cell treatment for Huntington's disease
Tampa, FL. (PRWEB) March 26, 2015
This month, the Lung Institute has started treating people suffering from chronic lung diseases with stem cells extracted from their bone marrow. This treatment protocol is added to the two other treatment options offered by the Lung Institute: venous (blood-derived) and adipose (fat-derived) stem cell therapy.
The bone marrow and adipose treatments offer the highest concentration of stem cells and allow for the cells to be reintroduced directly into the lungs through a nebulizer. Given this added benefit, most patients in the past opted to receive the adipose treatment over venous. However, many patients have other medical conditions that preclude them from choosing the adipose treatment. Since the number of stem cells harvested from a bone marrow procedure matches that of the adipose procedure, patients that have previously only qualified for the venous procedure are now eligible for a treatment option that produces the highest chance of success.
Patients are often surprised by the simplicity of these minimally invasive procedures, but with cutting-edge technology and the patient-centric clinical team at the Lung Institute, patients can rest assured that they are in good hands. Throughout the entire treatment process, patients have the opportunity to get any questions immediately answered by our knowledgeable medical staff. The Lung Institute clinical team remains in contact with patients after treatment and works together with the patients physician and pulmonologist to create a strong support system for the patient.
About the Lung Institute At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve their quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (855) 313-1149.
Read the original post: